{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Drug Science Podcast","title":"85. MDMA, Ketamine and Cannabis with Prof Valerie Curran","html":"","width":"100%","height":180,"duration":2972,"description":"In this episode, Professr Valerie Curran, discusses the psychological effects of drugs that act on the human brain. \nValerie Curren holds the position of Professorial Fellow in the Neuroscience of Addiction and Mental Health Program at ACU's Healthy Brain and Mind Research Centre. She has an esteemed background as an Emeritus Professor of Psychopharmacology at University College London (UCL), having established the UCL Clinical Psychopharmacology Unit in 1996. Furthermore, she is a founding member of the charity Drug Science and serves as an advisor to the UK All Party Parliamentary Group on Drug Policy Reform.\nTune in to learn about her latest research into the short- and long-term effects of psychoactive drugs on mental health, cognition, memory and the brain as well as how CBD combined with psychological therapy may aid the treatment of cannabis use disorder.\nBenzos\n\nMDMA\n\nAlcohol\n\nCannabis\n\nCBD\n\nTHC\n\nKetamine\n\nMDMA midweek blues paper – in journal Addiction (mid 90s) \nInappropriate benzodiazepine use in elderly patients and its reduction \nCombined and individual effects of CBD and THC on memory\n\nDavid Nutt and Psilocybin in Australia  \nCannabis potency\n\nCBD treating clinical psychosis\n\nCBD in treating cannabis use disorder\n\nProject 2021\n\nMedical cannabis reducing opiate use\n\nJon snow takes cannabis \nEndocannabinoid system\n\nSupport the podcast","thumbnail_url":"https://img.transistorcdn.com/_9zCPWqg8qEZMbGPRHXpyfEoB-tp-Loq_USjII37f7A/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE4MjI3LzE2MTgz/MDc3MDYtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}